bf/NYSE:AVNS_icon.jpeg

COM:AVANOS

Avanos Medical

  • Stock

USD

Last Close

18.02

22/11 21:00

Market Cap

890.08M

Beta: -

Volume Today

347.33K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
293.65M
-
284.35M
3.17%
293.15M
3.09%
287.85M
1.81%
181.80M
36.84%
106.25M
41.56%
133.65M
25.79%
157.40M
17.77%
159.60M
1.40%
170.30M
6.70%
176.75M
3.79%
average payables
110.35M
-
143.60M
30.13%
165.95M
15.56%
168.15M
1.33%
172.15M
2.38%
170.55M
0.93%
126.45M
25.86%
75.30M
40.45%
62M
17.66%
62.15M
0.24%
62.10M
0.08%
average receivables
193.50M
-
218.60M
12.97%
229.30M
4.89%
207.40M
9.55%
196.55M
5.23%
176.75M
10.07%
157.15M
11.09%
165.85M
5.54%
149.55M
9.83%
149.55M
0%
155.35M
3.88%
book value per share
44.70
-
32.04
28.31%
22.65
29.31%
23.66
4.44%
25.97
9.77%
27.48
5.83%
26.58
3.29%
26.29
1.10%
26.28
0.04%
27.53
4.77%
26.53
3.64%
capex per share
-1.05
-
-1.69
60.13%
-1.51
10.41%
-0.62
58.68%
-0.92
47.82%
-1.04
12.69%
-1.06
2.19%
-0.42
60.25%
-0.44
3.31%
-0.41
5.74%
-0.38
7.18%
capex to depreciation
-0.71
-
-0.92
29.81%
-1.08
17.11%
-0.45
58.54%
-0.73
62.68%
-1.47
101.87%
-1.37
6.44%
-0.47
65.66%
-0.55
16.45%
-0.40
26.21%
-0.39
4.57%
capex to operating cash flow
-0.22
-
-0.53
142.42%
-0.72
35.90%
-0.15
78.63%
-0.30
94.37%
0.34
212.56%
0.68
101.41%
8.08
1,089.64%
-0.24
102.98%
-0.21
11.74%
-0.55
158.75%
capex to revenue
-0.03
-
-0.05
60.72%
-0.04
4.75%
-0.02
59.13%
-0.07
286.50%
-0.08
6.57%
-0.07
3.64%
-0.03
61.04%
-0.03
0.20%
-0.02
16.55%
-0.03
12.32%
cash per share
0.95
-
3.20
237.71%
2.78
13.18%
2.44
12.23%
4.69
92.40%
8.15
73.53%
4.31
47.05%
2.33
45.92%
2.46
5.62%
2.72
10.52%
1.88
30.88%
days of inventory on hand
97.85
-
91.97
6.01%
106.13
15.39%
96.15
9.40%
121.05
25.89%
169.51
40.04%
180.28
6.35%
180.52
0.14%
144.25
20.09%
187.73
30.14%
204.98
9.19%
days payables outstanding
40.60
-
54.81
34.99%
57.12
4.23%
61.08
6.93%
227.48
272.42%
237.24
4.29%
102.56
56.77%
72.25
29.55%
54.13
25.08%
66.98
23.74%
70.71
5.57%
days sales outstanding
44.24
-
51.06
15.42%
52.09
2.03%
43.58
16.35%
121.15
178.02%
84.21
30.49%
85.70
1.77%
85.74
0.04%
64.31
24.99%
74.74
16.21%
77.41
3.58%
debt to assets
0.00
-
0.25
5,154.00%
0.29
14.83%
0.28
3.31%
0.26
5.34%
0.14
48.93%
0.18
33.84%
0.15
17.74%
0.12
20.94%
0.16
33.26%
0.11
31.82%
debt to equity
0.01
-
0.43
7,353.95%
0.55
28.40%
0.53
4.13%
0.48
8.99%
0.19
60.05%
0.26
34.69%
0.20
23.01%
0.15
25.08%
0.22
46.18%
0.15
32.56%
dividend yield
0.32
-
earnings yield
0.08
-
0.01
84.20%
-0.27
2,238.64%
0.02
108.43%
0.04
58.87%
0.03
25.87%
-0.03
205.20%
-0.01
56.65%
0.00
125.14%
0.04
1,176.10%
-0.06
248.59%
enterprise value
1.87B
-
2.60B
38.85%
2.01B
22.98%
2.19B
9.16%
2.52B
15.25%
1.98B
21.61%
1.72B
12.80%
2.33B
35.15%
1.74B
25.48%
1.42B
18.15%
1.17B
17.92%
enterprise value over ebitda
6.31
-
14.26
125.91%
12.38
13.18%
14.29
15.43%
133.46
834.23%
47.30
64.56%
-142.50
401.24%
-1.17K
717.69%
36.64
103.14%
11.57
68.43%
11.84
2.41%
ev to operating cash flow
8.38
-
17.60
110.10%
20.54
16.72%
11.59
43.57%
17.49
50.90%
-13.58
177.63%
-23.14
70.42%
-932.15
3,927.61%
19.89
102.13%
15.64
21.39%
36.01
130.27%
ev to sales
1.12
-
1.56
39.29%
1.27
18.20%
1.37
7.93%
4.12
200.07%
3.03
26.50%
2.47
18.46%
3.26
31.90%
2.33
28.46%
1.73
25.68%
1.73
0.04%
free cash flow per share
3.76
-
1.49
60.32%
0.58
60.85%
3.43
486.94%
2.16
37.03%
-4.13
291.14%
-2.63
36.29%
-0.47
81.93%
1.38
390.25%
1.53
10.76%
0.31
79.48%
free cash flow yield
0.09
-
0.03
64.22%
0.02
46.72%
0.09
430.28%
0.05
49.57%
-0.09
297.07%
-0.08
15.32%
-0.01
86.73%
0.04
484.10%
0.06
41.91%
0.01
75.24%
graham net net
-1.41
-
-12.26
770.14%
-10.63
13.27%
-12.38
16.42%
-12.03
2.81%
0.46
103.85%
-2.80
704.25%
-1.98
29.46%
-0.80
59.32%
-3.13
289.87%
-3.86
23.09%
graham number
57.82
-
20.49
64.56%
68.30
233.30%
21.32
68.78%
31.47
47.57%
27.45
12.77%
24.01
12.50%
18.35
23.61%
7.99
56.42%
25.83
223.04%
28.14
8.94%
income quality
1.45
-
5.46
277.01%
-0.23
104.20%
4.74
2,171.97%
1.82
61.67%
-2.53
239.25%
1.62
164.10%
0.09
94.34%
16.79
18,165.85%
1.80
89.28%
-3.27
281.82%
intangibles to total assets
0.63
-
0.61
4.03%
0.51
15.35%
0.58
12.61%
0.42
28.10%
0.52
24.78%
0.55
5.45%
0.57
4.85%
0.59
3.00%
0.60
1.32%
0.61
2.15%
interest coverage
2.25K
-
15.72
99.30%
-11.41
172.60%
2.67
123.42%
-1.36
151.03%
0.02
101.39%
-3.71
19,706.40%
-2.96
20.42%
2.70
191.26%
7.40
174.38%
3.49
52.79%
interest debt per share
0.26
-
13.80
5,249.17%
13.12
4.93%
13.13
0.05%
13.09
0.30%
5.81
55.63%
7.15
23.14%
5.53
22.65%
3.97
28.29%
6.18
55.88%
4.20
32.05%
inventory turnover
3.73
-
3.97
6.39%
3.44
13.34%
3.80
10.37%
3.02
20.56%
2.15
28.59%
2.02
5.97%
2.02
0.14%
2.53
25.14%
1.94
23.16%
1.78
8.42%
invested capital
0.01
-
0.43
7,353.95%
0.55
28.40%
0.53
4.13%
0.48
8.99%
0.19
60.05%
0.26
34.69%
0.20
23.01%
0.15
25.08%
0.22
46.18%
0.15
32.56%
market cap
1.91B
-
2.12B
10.95%
1.56B
26.45%
1.72B
10.72%
2.16B
25.41%
2.11B
2.18%
1.60B
24.12%
2.19B
36.71%
1.67B
23.96%
1.27B
23.90%
1.05B
17.64%
net current asset value
180.20M
-
-351.50M
295.06%
-268.90M
23.50%
-375.80M
39.75%
180.20M
147.95%
177.40M
1.55%
4.10M
97.69%
50.90M
1,141.46%
87.90M
72.69%
4.10M
95.34%
30.90M
653.66%
net debt to ebitda
-0.11
-
2.67
2,561.80%
2.77
3.79%
3.04
9.68%
19.11
529.23%
-3.27
117.12%
-9.93
203.28%
-68.65
591.64%
1.46
102.12%
1.24
14.87%
1.23
0.54%
net income per share
3.32
-
0.58
82.48%
-9.15
1,671.41%
0.85
109.33%
1.69
98.39%
1.22
28.11%
-0.96
179.16%
-0.57
40.99%
0.11
119.00%
1.08
896.00%
-1.33
223.16%
operating cash flow per share
4.81
-
3.18
33.95%
2.10
34.08%
4.05
93.38%
3.08
23.95%
-3.08
200.12%
-1.57
49.26%
-0.05
96.66%
1.81
3,570.22%
1.94
6.79%
0.70
64.13%
payables turnover
8.99
-
6.66
25.92%
6.39
4.05%
5.98
6.48%
1.60
73.15%
1.54
4.11%
3.56
131.32%
5.05
41.94%
6.74
33.48%
5.45
19.19%
5.16
5.28%
receivables turnover
8.25
-
7.15
13.36%
7.01
1.99%
8.38
19.54%
3.01
64.03%
4.33
43.86%
4.26
1.74%
4.26
0.04%
5.68
33.31%
4.88
13.95%
4.71
3.46%
research and ddevelopement to revenue
0.02
-
0.02
11.06%
0.02
2.10%
0.03
25.81%
0.06
141.98%
0.06
2.60%
0.05
15.67%
0.05
9.65%
0.04
11.15%
0.04
13.97%
0.04
8.26%
return on tangible assets
0.17
-
0.03
83.89%
-0.44
1,706.71%
0.05
110.40%
0.06
35.65%
0.07
5.47%
-0.06
186.41%
-0.04
32.28%
0.01
120.90%
0.07
783.46%
-0.09
233.50%
revenue per share
36.06
-
35.93
0.37%
33.80
5.94%
34.17
1.10%
13.07
61.75%
13.82
5.75%
14.66
6.05%
14.95
2.04%
15.48
3.52%
17.48
12.94%
14.45
17.36%
roe
0.07
-
0.02
75.56%
-0.40
2,322.83%
0.04
108.94%
0.07
80.74%
0.04
32.06%
-0.04
181.85%
-0.02
40.33%
0.00
119.01%
0.04
850.62%
-0.05
227.81%
roic
0.07
-
0.01
81.99%
-0.24
1,923.14%
0.04
115.58%
-0.01
128.52%
0.00
101.42%
-0.02
15,858.25%
-0.01
45.03%
0.01
140.16%
0.04
569.58%
0.05
28.30%
sales general and administrative to revenue
0.21
-
0.25
21.19%
0.25
0.30%
0.26
2.00%
0.53
103.73%
0.52
0.79%
shareholders equity per share
44.70
-
32.04
28.31%
22.65
29.31%
23.66
4.44%
25.97
9.77%
27.48
5.83%
26.58
3.29%
26.29
1.10%
26.28
0.04%
27.53
4.77%
26.53
3.64%
stock based compensation to revenue
0.00
-
0.00
32.09%
0.01
89.56%
0.01
3.78%
0.02
121.65%
0.02
21.87%
0.02
6.49%
0.02
12.47%
0.02
4.72%
0.02
9.38%
0.02
21.02%
tangible asset value
507.80M
-
-43.20M
108.51%
27.50M
163.66%
-96.30M
450.18%
301.80M
413.40%
345.40M
14.45%
280M
18.93%
296.30M
5.82%
321.10M
8.37%
220.80M
31.24%
200.70M
9.10%
tangible book value per share
10.92
-
-0.93
108.50%
0.59
163.59%
-2.07
450.07%
6.45
412.06%
7.32
13.48%
5.88
19.62%
6.20
5.38%
6.68
7.69%
4.71
29.48%
4.31
8.52%
working capital
274.70M
-
328.90M
19.73%
360.80M
9.70%
269.10M
25.42%
770.90M
186.47%
449.30M
41.72%
326M
27.44%
300.90M
7.70%
279.40M
7.15%
314M
12.38%
252.40M
19.62%

All numbers in USD (except ratios and percentages)